Ledger.Open graph →
SEC Form D · filed February 28, 2022

Marlinspike Therapeutics, Inc

Offering
$65.0M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Joseph Yanchik · Cambridge, MADirectorSeth Harrison · Cambridge, MADirectorAlexander Mccampbell · Cambridge, MADirectorRaj Chopra · Cambridge, MAExec · DirectorSeth Harrison · New York, NYDirectorAlexander Mccampbell · Cambridge, MADirectorRaj Chopra · Cambridge, MAExec · DirectorJoseph Yanchik · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗